Basalt Rehabilitation, Wassenaarseweg 501, 2333 AL, Leiden, The Netherlands.
Department of Rehabilitation, Haaglanden Medical Center, The Hague, The Netherlands.
Qual Life Res. 2022 Dec;31(12):3305-3315. doi: 10.1007/s11136-022-03149-4. Epub 2022 May 14.
Both the International Consortium for Health Outcomes Measurement and the National Institutes of Health recommend the use of Patient-Reported Outcomes Measurement Information System (PROMIS®) measures in clinical care and research for stroke patients. This study aimed to systematically review the literature on the measurement properties and interpretability of PROMIS measures in stroke patients.
Nine databases were searched from January 1st, 2007 till April 12th, 2021 for studies concerning the measurement properties and interpretability of PROMIS measures in stroke patients. The findings of these studies were analyzed according to the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guideline for systematic reviews of Patient-Reported Outcome Measures (PROMs).
Ten studies were included. The PROMIS Global Health was studied the most: its two subscales had sufficient structural validity in one study of very good quality, sufficient construct validity with > 75% of hypotheses tested confirmed (high GRADE rating), sufficient internal consistency, i.e. α ≥ 0.70 in two studies (high GRADE rating), sufficient reliability, i.e. ICC ≥ 0.70 in one study of doubtful quality, and indeterminate responsiveness in one study of inadequate quality. For other PROMIS measures, the measurement properties and interpretability were limitedly studied.
The PROMIS Global Health showed sufficient structural and construct validity and internal consistency in stroke patients. There is a need for further research on content validity, structural validity, and measurement invariance of PROMIS measures in stroke patients. Trial Registration Information: CRD42020203044 (PROSPERO).
国际健康结果测量联合会和美国国立卫生研究院均建议在脑卒中患者的临床护理和研究中使用患者报告结局测量信息系统（PROMIS®）量表。本研究旨在系统地回顾关于脑卒中患者 PROMIS 量表测量特性和可解释性的文献。
从 2007 年 1 月 1 日至 2021 年 4 月 12 日，我们在 9 个数据库中搜索了有关脑卒中患者 PROMIS 量表测量特性和可解释性的研究。根据患者报告结局测量（PROMs）系统评价的共识基础标准选择健康测量仪器（COSMIN）指南，分析这些研究的结果。
纳入了 10 项研究。PROMIS 全球健康量表研究最多：一项研究质量非常好，其两个分量表具有充分的结构有效性，超过 75%的假设得到证实（高 GRADE 评分），具有充分的构建有效性；两项研究的内部一致性较高，α≥0.70（高 GRADE 评分）；一项研究的可靠性较高，ICC≥0.70（可疑质量）；一项研究的反应度不确定（质量不足）。对于其他 PROMIS 量表，其测量特性和可解释性研究有限。
PROMIS 全球健康量表在脑卒中患者中表现出充分的结构和构建有效性以及内部一致性。需要进一步研究 PROMIS 量表在脑卒中患者中的内容有效性、结构有效性和测量不变性。
CRD42020203044（PROSPERO）。
